Blujepa (gepotidacin) is a new antibiotic recently approved by the FDA for treating bladder infections caused by certain bacteria in women and girls ages 12 and older. Blujepa works differently ...

"We are proud to have developed Blujepa, the first in a new class of oral antibiotics for uUTIs in nearly three decades, and to bring another option to patients given recurrent infections and ...

The drug is manufactured by the pharmaceutical company GSK and is sold under the name Blujepa. After reaching a historic low in 2009, cases of gonorrhea in the United States steadily increased ...

The rise in antibacterial resistance to common antibiotics has led to the growth of drug-resistant forms of gonorrhea, sometimes referred to as “super gonorrhea.” At the moment, just a handful ...

The drug is sold under the name Blujepa. A new treatment option is important, experts say, because bacteria that commonly cause STIs are increasingly becoming resistant to the standard antibiotics ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a new study finds. This could put the medication, called gepotidacin ...